دورية أكاديمية

Detecting actionable PIK3CA mutations through next-generation sequencing (NGS) in hormone receptor positive (HR+)/HER2-negative advanced/metastatic breast cancer (MBC): a real-life experience

التفاصيل البيبلوغرافية
العنوان: Detecting actionable PIK3CA mutations through next-generation sequencing (NGS) in hormone receptor positive (HR+)/HER2-negative advanced/metastatic breast cancer (MBC): a real-life experience
المؤلفون: Caldart, A., Fiorio, E., Zanelli, S., Biondani, P., Parolin, V., Pellini, F., Montemezzi, S., Nottegar, A., Caliò, A., Zampiva, I., Merler, S., Mongillo, M., Avesani, B., Borghesani, G., Giontella, E., Scarpa, A., Milella, M.
المصدر: European Journal of Cancer ; volume 175, page S38-S39 ; ISSN 0959-8049
بيانات النشر: Elsevier BV
سنة النشر: 2022
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Cancer Research, Oncology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/s0959-8049(22)01453-8
الإتاحة: https://doi.org/10.1016/s0959-8049Test(22)01453-8
https://api.elsevier.com/content/article/PII:S0959804922014538?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0959804922014538?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/
رقم الانضمام: edsbas.388F39E8
قاعدة البيانات: BASE